362 related articles for article (PubMed ID: 9525971)
41. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
[TBL] [Abstract][Full Text] [Related]
42. Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression.
Kogai T; Curcio F; Hyman S; Cornford EM; Brent GA; Hershman JM
J Endocrinol; 2000 Oct; 167(1):125-35. PubMed ID: 11018760
[TBL] [Abstract][Full Text] [Related]
43. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
44. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.
Wang ZF; Liu QJ; Liao SQ; Yang R; Ge T; He X; Tian CP; Liu W
Tumori; 2011; 97(4):540-6. PubMed ID: 21989446
[TBL] [Abstract][Full Text] [Related]
45. Effect of oxygen concentrations on sodium iodide symporter expression and iodide uptake and hCG expression in human choriocarcinoma BeWo cells.
Li H; Landers K; Patel J; Richard K; Mortimer RH
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1085-91. PubMed ID: 21406611
[TBL] [Abstract][Full Text] [Related]
46. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.
Kogai T; Endo T; Saito T; Miyazaki A; Kawaguchi A; Onaya T
Endocrinology; 1997 Jun; 138(6):2227-32. PubMed ID: 9165005
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
48. Iodide symporter gene expression in normal and transformed rat thyroid cells.
Trapasso F; Iuliano R; Chiefari E; Arturi F; Stella A; Filetti S; Fusco A; Russo D
Eur J Endocrinol; 1999 May; 140(5):447-51. PubMed ID: 10229912
[TBL] [Abstract][Full Text] [Related]
49. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide.
Josefsson M; Grunditz T; Ohlsson T; Ekblad E
Acta Physiol Scand; 2002 Jun; 175(2):129-37. PubMed ID: 12028133
[TBL] [Abstract][Full Text] [Related]
50. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
Shimura H; Haraguchi K; Miyazaki A; Endo T; Onaya T
Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of iodide transport defect but normal iodide organification in nonfunctioning nodules of human thyroid glands.
Field JB; Larsen PR; Yamashita K; Mashiter K; Dekker A
J Clin Invest; 1973 Oct; 52(10):2404-10. PubMed ID: 4353998
[TBL] [Abstract][Full Text] [Related]
52. Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers.
Peyrottes I; Navarro V; Ondo-Mendez A; Marcellin D; Bellanger L; Marsault R; Lindenthal S; Ettore F; Darcourt J; Pourcher T
Eur J Endocrinol; 2009 Feb; 160(2):215-25. PubMed ID: 19029227
[TBL] [Abstract][Full Text] [Related]
53. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas.
Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M
Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710
[TBL] [Abstract][Full Text] [Related]
54. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.
Pohlenz J; Medeiros-Neto G; Gross JL; Silveiro SP; Knobel M; Refetoff S
Biochem Biophys Res Commun; 1997 Nov; 240(2):488-91. PubMed ID: 9388506
[TBL] [Abstract][Full Text] [Related]
55. Sodium/iodide symporter (NIS) and cytokines.
Schumm-Draeger PM
Exp Clin Endocrinol Diabetes; 2001; 109(1):32-4. PubMed ID: 11573136
[TBL] [Abstract][Full Text] [Related]
56. Low expression of sodium iodide symporter identifies aggressive thyroid tumors.
Ward LS; Santarosa PL; Granja F; da Assumpção LV; Savoldi M; Goldman GH
Cancer Lett; 2003 Oct; 200(1):85-91. PubMed ID: 14550956
[TBL] [Abstract][Full Text] [Related]
57. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas.
Russo D; Manole D; Arturi F; Suarez HG; Schlumberger M; Filetti S; Derwahl M
Thyroid; 2001 Jan; 11(1):37-9. PubMed ID: 11272095
[TBL] [Abstract][Full Text] [Related]
58. A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect.
Matsuda A; Kosugi S
J Clin Endocrinol Metab; 1997 Dec; 82(12):3966-71. PubMed ID: 9398697
[TBL] [Abstract][Full Text] [Related]
59. Semi-quantitative comparison of the differentiation markers and sodium iodide symporter messenger ribonucleic acids in papillary thyroid carcinomas using RT-PCR.
Tanaka K; Otsuki T; Sonoo H; Yamamoto Y; Udagawa K; Kunisue H; Arime I; Yamamoto S; Kurebayashi J; Shimozuma K
Eur J Endocrinol; 2000 Apr; 142(4):340-6. PubMed ID: 10754474
[TBL] [Abstract][Full Text] [Related]
60. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
